tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ:ACAD
US Market
ACAD
ACADIA Pharmaceuticals
RESEARCH TOOLSreports

ACADIA Pharmaceuticals (ACAD) Stock News & Sentiment

Compare
2,438 Followers
ACADIA Pharmaceuticals: U.S. Commercial Execution and Pipeline Optionality Drive Undervalued Buy Thesis Despite EU Trofinetide Delay
Premium
Ratings
ACADIA Pharmaceuticals: U.S. Commercial Execution and Pipeline Optionality Drive Undervalued Buy Thesis Despite EU Trofinetide Delay
3d ago
ACAD
ACADIA Pharmaceuticals Clarifies Form 8-K Disclosure Treatment
Premium
Company Announcements
ACADIA Pharmaceuticals Clarifies Form 8-K Disclosure Treatment
23d ago
8K
ACAD
ACADIA Pharmaceuticals: Strong Financial Performance and Strategic Growth Initiatives Drive Buy Rating
Premium
Ratings
ACADIA Pharmaceuticals: Strong Financial Performance and Strategic Growth Initiatives Drive Buy Rating
3M ago
ACAD
ACADIA Pharmaceuticals Q3 2025 Earnings Call Highlights
Premium
Company Announcements
ACADIA Pharmaceuticals Q3 2025 Earnings Call Highlights
3M ago
ACAD
ACADIA Pharmaceuticals: Strong Growth Prospects and Strategic Positioning Justify Buy Rating
Premium
Ratings
ACADIA Pharmaceuticals: Strong Growth Prospects and Strategic Positioning Justify Buy Rating
3M ago
ACAD
ACADIA Pharmaceuticals: Hold Rating Amid Stable U.S. Performance and Growth Potential
Premium
Ratings
ACADIA Pharmaceuticals: Hold Rating Amid Stable U.S. Performance and Growth Potential
3M ago
ACAD
ACADIA Pharmaceuticals: Hold Rating Amid Growth Prospects and Uncertainties
Premium
Ratings
ACADIA Pharmaceuticals: Hold Rating Amid Growth Prospects and Uncertainties
3M ago
ACAD
More ACAD News >

ACAD News on the Web

Are these 2 ASX healthcare shares a buying opportunity after yesterday's crash?
The Motley Fool
Bearish
ACAD Maintains Outperform Rating Despite Lowered Price Target | ACAD Stock News
GuruFocus News
Neutral
ACADIA Pharmaceuticals (ACAD) Analyst Rating Reaffirmed by Citizens | ACAD Stock News
GuruFocus News
Bullish
Guess which ASX 200 healthcare share is crashing 22% on Tuesday on European blow
The Motley Fool
Neutral
Acadia Pharmaceuticals (ACAD) Encounters Hurdle in EU Approval for Trofinetide
GuruFocus News
Bearish
John Hussman's Strategic Moves: Qualcomm Inc. Takes Center Stage with 1.13% Portfolio Impact
GuruFocus News
Neutral
Acadia Pharmaceuticals price target raised to $31 from $27 at BofA
TipRanks News
Neutral
Bank of America Securities Remains a Hold on ACADIA Pharmaceuticals (ACAD)
TipRanks News
Neutral

News Score - Last 7 Days

Negative
ACAD
Sector Average
Media Buzz
This Week7 articles
Weekly Average4.75 articles
News Sentiment
This Week33%
Sector Average73%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ACAD’s Media Buzz Sentiment?
7 articles about ACAD were published this week. In an average week, 4.75 articles are published.
    What is ACAD’s weekly average amount of articles?
    In an average week, 4.75 articles about ACAD are published.
      What is ACAD’s News Sentiment?
      33% of articles about ACAD were positive this week, compared to its sector average of 73%.
        Healthcare Stocks that are Trending in the News
        DVADaVita
        TECHBio-Techne
        STARStrides Pharma Science Ltd
        ALGNAlign Tech
        PLXProtalix
        Showing the stocks with the most bullish news sentiment over the past week